Exploring This Week In Cardiology Jun 22 2026
If you are looking for information about This Week In Cardiology Jun 22 2026, you have come to the right place.
- Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid ...
- Listener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, ...
- A life-long treatment for high LDL, a VESALIUS subanalysis, tirzepatide beats semaglutide again, arrhythmia burden in
- Chemical cardioversion in the ED, HF monitoring, weight loss in AF, and surgical LAA excision are the topics John Mandrola, MD, ...
- PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA ...
In-Depth Information on This Week In Cardiology Jun 22 2026
Welcome to Welcome to Listener feedback on valvular heart disease, statins and frailty, left atrial posterior wall ablation fails again, interpreting medical ... Listener feedback, transcatheter tricuspid valve replacement, a new metabolic disease called CKM, the ARISE-FLUIDS Trial, the ...
Listener feedback, the huge CLOSURE-AF trial of LAAC vs best medical therapy, previews of CHAMPION AF, and the ...
We hope this detailed breakdown of This Week In Cardiology Jun 22 2026 was helpful.
